SCHEMBL557076

SCHEMBL557076

CC(=CC(=O)O)c1ccc(OP=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.51
NR4A2 P43354 1/20 0.51
NR4A3 Q92570 1/20 0.51
TBXAS1 P24557 2/20 0.41
ESR1 P03372 1/20 0.41
LTB4R Q15722 8/20 0.40
LTB4R2 Q9NPC1 7/20 0.40
F2 P00734 1/20 0.38
PLG P00747 1/20 0.38
PRSS1 P07477 1/20 0.38
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
ELANE P08246 1/20 0.36
HSD17B10 Q99714 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16070000 1.00 NR4A1 (0.51) NR4A1NR4A2NR4A3TBXAS1ESR1
SCHEMBL16069999 1.00 NR4A1 (0.51) NR4A1NR4A2NR4A3TBXAS1ESR1
SCHEMBL6655426 0.80 CA1 (0.59) NR4A1NR4A2NR4A3MAPTALDH1A1
SCHEMBL6655419 0.80 CA1 (0.59) NR4A1NR4A2NR4A3MAPTALDH1A1
SCHEMBL6655424 0.80 CA1 (0.59) NR4A1NR4A2NR4A3MAPTALDH1A1
SCHEMBL9820463 0.79 ELANE (0.59) NR4A1NR4A2NR4A3TBXAS1ESR1
Hydrochloric Acid SCHEMBL9445571 0.79 CA1 (0.57) NR4A1NR4A2NR4A3MAPTALDH1A1
SCHEMBL557075 0.78 BLM (0.51) NR4A1NR4A2NR4A3TBXAS1ESR1
SCHEMBL28297767 0.77 MAPT (0.61) MAPTHPGDRAB9AALDH1A1
Hydrochloric Acid SCHEMBL9820527 0.77 ELANE (0.58) NR4A1NR4A2NR4A3TBXAS1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8841257-B2 Inhibitors of STAT3 and uses thereof BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-09-23 US disclosed
US-20120035114-A1 INHIBITORS OF STAT3 AND USES THEREOF BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2012-02-09 US disclosed
WO-2010118309-A2 INHIBITORS OF STAT3 AND USES THEREOF BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035114-A1 INHIBITORS OF STAT3 AND USES THEREOF STAT3, JAK2, STAT6 NR4A1 1016/4885NR4A2 764/4885NR4A3 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.